Abstract #0219
Pharmacokinetic Analysis for Differentiating Benign and Malignant Spinal Tumors Measured by DCE-MRI
Ning Lang 1 , Min-Ying Lydia Su 2 , Hon J Yu 2 , and Huishu Yuan 1
1
Department of Radiology, Peking University
Third Hospital, Beijing, China,
2
Tu
& Yuen Center for Functional Onco-Imaging, Department of
Radiological Sciences, University of California, Irvine,
CA, United States
DCE-MRI was performed to differentiate 4 spinal lesions
(9 myeloma, 22 metastatic cancer, 7 lymphoma, 22 benign
tuberculosis). The peak signal enhancement, the steepest
wash-in slope and wash-out slope were measured.
Two-compartmental pharmacokinetic model was used to
obtain Ktrans and kep, by using three different blood
curves (fast, medium, and slow). The results showed that
kep analyzed by using fast or medium blood curves is the
best parameter to differentiate these 4 lesion groups.
Ktrans is associated with wash-in slope and kep is
associated with wash-out slope. The slow blood curve is
not suitable for a short DCE period.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
